Next Article in Journal
Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
Next Article in Special Issue
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial
Previous Article in Journal
Interrogation of IDH1 Status in Gliomas by Fourier Transform Infrared Spectroscopy
Previous Article in Special Issue
No Impact of Smoking Status on Breast Cancer Tumor Infiltrating Lymphocytes, Response to Neoadjuvant Chemotherapy and Prognosis
 
 
Article

Article Versions Notes

Cancers 2020, 12(12), 3681; https://doi.org/10.3390/cancers12123681
Action Date Notes Link
article xml file uploaded 8 December 2020 12:00 CET Original file -
article xml uploaded. 8 December 2020 12:00 CET Update https://www.mdpi.com/2072-6694/12/12/3681/xml
article pdf uploaded. 8 December 2020 12:00 CET Version of Record https://www.mdpi.com/2072-6694/12/12/3681/pdf
article supplementary file uploaded. 8 December 2020 12:00 CET - https://www.mdpi.com/2072-6694/12/12/3681#supplementary
article html file updated 8 December 2020 12:01 CET Original file -
article html file updated 23 July 2022 04:15 CEST Update https://www.mdpi.com/2072-6694/12/12/3681/html
Back to TopTop